BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9873951)

  • 1. Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma.
    Fisher WE; Muscarella P; Boros LG; Schirmer WJ
    Int J Pancreatol; 1998 Dec; 24(3):169-80. PubMed ID: 9873951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of gastrointestinal hormones and synthetic analogues on the growth of pancreatic cancer.
    Robertson JF; Watson SA; Hardcastle JD
    Int J Cancer; 1995 Sep; 63(1):69-75. PubMed ID: 7558455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of gastrointestinal hormones in pancreatic cancer.
    Guo YS; Townsend CM
    J Hepatobiliary Pancreat Surg; 2000; 7(3):276-85. PubMed ID: 10982627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters.
    Szepeshazi K; Schally AV; Cai RZ; Radulovic S; Milovanovic S; Szoke B
    Cancer Res; 1991 Nov; 51(21):5980-6. PubMed ID: 1682039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth effects of regulatory peptides on human pancreatic cancer lines PANC-1 and MIA PaCa-2.
    Liehr RM; Melnykovych G; Solomon TE
    Gastroenterology; 1990 Jun; 98(6):1666-74. PubMed ID: 2186957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibiting effect of a chalone-containing extract of calf pancreatic tissue on the proliferative activity of normal and tumorous pancreatic cells in vitro and in vivo].
    Mkrtchian LN; Khachaturova TS; Shukurian SG; Aleksanian KA; Melik-Shakhnazarian RB
    Eksp Onkol; 1988; 10(4):63-6. PubMed ID: 2972536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuro-hormonal control of pancreatic function in man and its failure.
    Greenberg GR
    Scand J Gastroenterol Suppl; 1983; 82():101-9. PubMed ID: 6138850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of insulin and somatostatin on the growth and the colony formation of two human pancreatic cancer cell lines.
    Takeda Y; Escribano MJ
    J Cancer Res Clin Oncol; 1991; 117(5):416-20. PubMed ID: 1679759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal therapy of pancreatic carcinoma. Rationale and perspectives.
    Perilli D; Mansi C; Savarino V; Celle G
    Int J Pancreatol; 1993 Jun; 13(3):159-68. PubMed ID: 8103783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of anti-tumor drugs and gastrointestinal hormones on the growth of pancreatic duct cell adenocarcinoma in homologous transplanted animal models].
    Ohyama K
    Hokkaido Igaku Zasshi; 1985 Mar; 60(2):206-16. PubMed ID: 2987090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic significance of gastrointestinal hormones].
    Eysselein VE; Singer MV
    Schweiz Med Wochenschr; 1986 Jan; 116(1):19-26. PubMed ID: 2868523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide hormone influence on exocrine pancreatic cancer.
    Andrén-Sandberg A
    Eur J Surg Oncol; 1989 Jun; 15(3):236-41. PubMed ID: 2567682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vagal stimulation on pancreatic secretion and on blood levels of gastrin, cholecystokinin, secretin, vasoactive intestinal peptide, and somatostatin.
    Guzman S; Chayvialle JA; Banks WA; Rayford PL; Thompson JC
    Surgery; 1979 Aug; 86(2):329-36. PubMed ID: 462378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel therapeutic approach for cancer using four cardiovascular hormones.
    Vesely DL; Clark LC; Garces AH; McAfee QW; Soto J; Gower WR
    Eur J Clin Invest; 2004 Oct; 34(10):674-82. PubMed ID: 15473892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of DNA synthesis in pancreatic duct cells by gastrointestinal hormones: interaction with other growth factors.
    Mangino MM; Hubchak S; Scarpelli DG
    Pancreas; 1992; 7(3):271-9. PubMed ID: 1594548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormonal changes in diseases of the gastrointestinal tract].
    Klimes I
    Vnitr Lek; 1989 Jul; 35(7):701-9. PubMed ID: 2800378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
    Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
    Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New views on gastrointestinal hormones].
    Domschke W; Domschke S
    Fortschr Med; 1977 Apr; 95(14):967-71. PubMed ID: 856699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurohormonal control of pancreatic secretion. A review.
    Singh M; Webster PD
    Gastroenterology; 1978 Feb; 74(2 Pt 1):294-309. PubMed ID: 340322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal control of pancreatic cancer growth.
    Liebow C; Hierowski M; duSapin K
    Pancreas; 1986; 1(1):44-8. PubMed ID: 2883646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.